HEMOPHILIA B WITH INHIBITORS
Clinical trials for HEMOPHILIA B WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HEMOPHILIA B WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HEMOPHILIA B WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hemophilia patients with inhibitors: STSP-0601 enters phase 3 trial
Disease control Recruiting nowThis Phase 3 trial is testing STSP-0601, an injectable drug, to control bleeding episodes in people with hemophilia A or B who have developed inhibitors (antibodies that block standard treatment). The study will enroll 40 participants aged 12 to 70 and measure how well the drug s…
Matched conditions: HEMOPHILIA B WITH INHIBITORS
Phase: PHASE3 • Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New blood tests aim to make haemophilia treatment safer for patients with inhibitors
Knowledge-focused Recruiting nowThis study is testing new blood tests to see if they can better measure how well bleeding treatments work in people with haemophilia who have developed inhibitors (antibodies that block standard treatment). The researchers will take blood samples from 20 patients before and after…
Matched conditions: HEMOPHILIA B WITH INHIBITORS
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:42 UTC